The present application relates to an amine compound, which is suitable for use in electronic devices, in particular organic electroluminescent devices (OLEDs). Furthermore, it relates to electronic devices comprising the compound, in particular OLEDs. Furthermore, it relates to a method for synthesizing the above-mentioned amine compound.

The present application relates to an amine compound, which is suitable for use in electronic devices, in particular organic electroluminescent devices (OLEDs). Furthermore, it relates to electronic devices comprising the compound, in particular OLEDs. Furthermore, it relates to a method for synthesizing the above-mentioned amine compound.

Provided are a cathode active material for secondary batteries, the cathode active material comprising a charge-transfer complex in which an electron donor and an electron acceptor are bonded to each other, wherein the electron donor and the electron acceptor are bonded to each other by intermolecular interaction, and a method of producing the cathode active material.

Provided are a cathode active material for secondary batteries, the cathode active material comprising a charge-transfer complex in which an electron donor and an electron acceptor are bonded to each other, wherein the electron donor and the electron acceptor are bonded to each other by intermolecular interaction, and a method of producing the cathode active material.

A compound of formula (I),

##STR00001##

wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are selected from a saturated or unsaturated, branched or unbranched, cyclic or non-cyclic alkyl, or an amide, or a functional group, or a salt or a solvate thereof, or a protonated form thereof, and to the use thereof for the treatment of cancer.

A compound of formula (I),

##STR00001##

wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are selected from a saturated or unsaturated, branched or unbranched, cyclic or non-cyclic alkyl, or an amide, or a functional group, or a salt or a solvate thereof, or a protonated form thereof, and to the use thereof for the treatment of cancer.

Embodiments of the present invention disclose an organic compound, a preparation method thereof, and a display panel. The organic compound is represented by the following general formula:

##STR00001## wherein Ar comprises any one or a combination of hydrogen, an isotope of hydrogen, an aromatic group, an arylamine group, a heteroarylamine group, and a fused ring group; and R1 and R2 are each independently any one or a combination of alkyl, alkoxy, heteroalkyl, and an aromatic group. In the embodiments of the present invention, by adding other electron-donating groups on the basis of a phenazine-fused fluorene structure, organic compounds with high mobility are obtained.

Embodiments of the present invention disclose an organic compound, a preparation method thereof, and a display panel. The organic compound is represented by the following general formula:

##STR00001## wherein Ar comprises any one or a combination of hydrogen, an isotope of hydrogen, an aromatic group, an arylamine group, a heteroarylamine group, and a fused ring group; and R1 and R2 are each independently any one or a combination of alkyl, alkoxy, heteroalkyl, and an aromatic group. In the embodiments of the present invention, by adding other electron-donating groups on the basis of a phenazine-fused fluorene structure, organic compounds with high mobility are obtained.

An organic compound represented by the following general formula is provided.

##STR00001##

In the above formula (1), R.sub.11 to R.sub.15 each independently represent a hydrogen atom, an alkyl group, an alkoxy group, an aryl group, an aryloxy group, an aralkyl group, an acyl group, or a halogen atom provided that at least one of R.sub.11, R.sub.13, and R.sub.15 represents the alkoxy group or the aryloxy group; and R.sub.11 to R.sub.15 may form a ring structure therebetween, R.sub.5 and R.sub.6 each independently represent an alkyl group, an aryl group, or an aralkyl group. In addition, R.sub.21 to R.sub.24 each independently represent a hydrogen atom, an alkyl group, an alkoxy group, an aryl group, an aryloxy group, an aralkyl group, an acyl group, or a halogen atom and may form a ring structure therebetween. The above groups except the acyl group may be substituted when necessary.

An organic compound represented by the following general formula is provided.

##STR00001##

In the above formula (1), R.sub.11 to R.sub.15 each independently represent a hydrogen atom, an alkyl group, an alkoxy group, an aryl group, an aryloxy group, an aralkyl group, an acyl group, or a halogen atom provided that at least one of R.sub.11, R.sub.13, and R.sub.15 represents the alkoxy group or the aryloxy group; and R.sub.11 to R.sub.15 may form a ring structure therebetween, R.sub.5 and R.sub.6 each independently represent an alkyl group, an aryl group, or an aralkyl group. In addition, R.sub.21 to R.sub.24 each independently represent a hydrogen atom, an alkyl group, an alkoxy group, an aryl group, an aryloxy group, an aralkyl group, an acyl group, or a halogen atom and may form a ring structure therebetween. The above groups except the acyl group may be substituted when necessary.